Evidence map›Paper›PMID 25710412›Full record

Observational studyAIDS (London, England)2015

Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy.

Susie Huntington, Claire Thorne, Marie-Louise Newell, Jane Anderson, Graham P Taylor, Deenan Pillay, Teresa Hill, Pat A Tookey, Caroline Sabin, UK Collaborative HIV Cohort (UK CHIC) Study and 1 more

Abstract readObservational Study
In one paragraph

Observational study in AIDS (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Susie HuntingtonaPopulation, Policy and Practice Programme, UCL Institute of Child Health bHIV Epidemiology and Biostatistics Group, UCL Research Department of Infection and Population Health, London cHuman Development and Health, Faculty of Medicine, University of Southampton, Southampton dHomerton University Hospital NHS Foundation Trust eSection of Retrovirology and GU Medicine, Imperial College, London fAfrica Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa.
Claire Thorne
Marie-Louise Newell
Jane Anderson
Graham P Taylor
Deenan Pillay
Teresa Hill
Pat A Tookey
Caroline Sabin
UK Collaborative HIV Cohort (UK CHIC) Study
UK and Ireland National Study of HIV in Pregnancy and Childhood (NSHPC)

Funding

Department of HealthMedical Research Council G0600337Medical Research Council G0900274Medical Research Council MR/K006584/1Medical Research Council MR/M004236/1Wellcome Trust 097410
6 · The paper itself

Abstract

objectiveThe objective of this study is to assess whether pregnancy is associated with an increased risk of liver enzyme elevation (LEE) and severe LEE in HIV-positive women on antiretroviral therapy (ART).

designTwo observational studies: the UK Collaborative HIV Cohort (UK CHIC) study and the UK and Ireland National Study of HIV in Pregnancy and Childhood (NSHPC).

methodsCombined data from UK CHIC and NSHPC were used to identify factors associated with LEE (grade 1-4) and severe LEE (grade 3-4). Women starting ART in 2000-2012 were included irrespective of pregnancy status. Cox proportional hazards were used to assess fixed and time-dependent covariates including pregnancy status, CD4 cell count, drug regimen and hepatitis B virus/hepatitis C virus (HBV/HCV) coinfection.

resultsOne-quarter (25.7%, 982/3815) of women were pregnant during follow-up, 14.2% (n = 541) when starting ART. The rate of LEE was 14.5/100 person-years in and 6.0/100 person-years outside of pregnancy. The rate of severe LEE was 3.9/100 person-years in and 0.6/100 person-years outside of pregnancy. The risk of LEE and severe LEE was increased during pregnancy [LEE: adjusted hazard ratio (aHR) 1.66 (1.31-2.09); severe LEE: aHR 3.57 (2.30-5.54)], including in secondary analyses excluding 541 women pregnant when starting ART. Other factors associated with LEE and severe LEE included lower CD4 cell count (<250 cells/μl), HBV/HCV coinfection and calendar year.

conclusionAlthough few women developed severe LEE, this study provides further evidence that pregnancy is associated with an increased risk of LEE and severe LEE, reinforcing the need for regular monitoring of liver biomarkers during pregnancy.

Indexed as

Liver Function TestsAdolescentAdultAnti-Retroviral AgentsEnzymesFemaleHIV InfectionsHumansLiverMiddle AgedPregnancyPregnancy Complications, InfectiousUnited KingdomYoung AdultAnti-Retroviral AgentsEnzymes

Identifiers

PMID25710412
PMCPMC4439178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.